References
- Halm EA, Teirstein AS. Clinical practice: management of community-acquired pneumonia. N Engl J Med 2002:347:2039-45 https://doi.org/10.1056/NEJMcp020499
- Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia: etiology, prognosis, and treatment. Am Rev Respir Dis 1990:142:369-73 https://doi.org/10.1164/ajrccm/142.2.369
- Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997:336:243-50 https://doi.org/10.1056/NEJM199701233360402
- Ortqvist A, Sterner G, Nilsson JA. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 1985:17:377-86
- The British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987:62:195-220
- Jinks MF, Kelly CA. The pattern and significance of abnormal liver function tests in community-acquired pneumonia. Eur J Intern Med 2004:15:436-40 https://doi.org/10.1016/j.ejim.2004.06.011
- Sankaran RT, Mattana J, Pollack S, Bhat P, Ahuja T, Patel A, et al. Laboratory abnormalities in patients with bacterial pneumonia. Chest 1997:111:595-600 https://doi.org/10.1378/chest.111.3.595
- Park HP, Seo YW, Lee JE, Kim YH, Jang YY, Park SH, et al. Factors associated with early death in patients with community-acquired pneumonia. Tuberc Respir Dis 2005:58:607-13 https://doi.org/10.4046/trd.2005.58.6.607
- Oh HK, Seo JY, Kim DK, Choi JE, Mo EK, Park MJ, et al. Clinical characteristics and prognostic factors of severe community-acquired pneumonia. Tuberc Respir Dis 1997:44:1072-82 https://doi.org/10.4046/trd.1997.44.5.1072
- Choi WI, Sohn JH, Kwun OY, Heo JS, Whang JS, Han SB, et al. Clinical manifestation of patients dying of severe community acquired pneumonia. Tuberc Respir Dis 1994:41:537-45 https://doi.org/10.4046/trd.1994.41.5.537
- Loh LC, Khoo SK, Quah SY, Visvalingam V, Radhakrishnan A, Vijayasingham P, et al. Adult community-acquired pneumonia in Malaysia: prediction of mortality from severity assessment on admission. Respirology 2004:9:379-86 https://doi.org/10.1111/j.1440-1843.2004.00604.x
- Watari M, Ohe M, Kunimoto E, Tsukamoto R, Komagata H. Mortality and prognostic factors in patients with community-acquired pneumonia: an analysis of 231 cases. Nihon Kokyuki Gakkai Zasshi 2000:38: 509-17
- Ballmer PE. Causes and mechanisms of hypoalbuminaemia. Clin Nutr 2001:20:271-3 https://doi.org/10.1054/clnu.2001.0439
- Liao WS, Jefferson LS, Taylor JM. Changes in plasma albumin concentration, synthesis rate, and mRNA level during acute inflammation. Am J Physiol 1986:251:C928-34
- Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987:79:1635-41 https://doi.org/10.1172/JCI113000
- Deniz O, Tozkoparan E, Yaman H, Cakir E, Gumus S, Ozcan O, et al. Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/ HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia. Clin Biochem 2006:39:287-92. https://doi.org/10.1016/j.clinbiochem.2006.01.015
- Menendez R, Ferrando D, Valles JM, Martinez E, Perpina M. Initial risk class and length of hospital stay in community-acquired pneumonia. Eur Respir J 2001:18:151-6. https://doi.org/10.1183/09031936.01.00090001
- Klar A, Shoseyov D, Berkun Y, Brand A, Braun J, Shazberg G, et al. Intestinal protein loss and hypoalbuminemia in children with pneumonia. J Pediatr Gastroenterol Nutr 2003:37:120-3 https://doi.org/10.1097/00005176-200308000-00007
- Porat S, Bhatia N, Barnett DW. A child with severe pneumonia, pleural effusion and acute hypoalbuminemia. Clin Pediatr 2002:41:199-200 https://doi.org/10.1177/000992280204100318
- Hedlund JU, Hansson LO, Ortqvist AB. Hypoalbuminemia in hospitalized patients with communityacquired pneumonia. Arch Intern Med 1995:155:1438-42 https://doi.org/10.1001/archinte.155.13.1438
- Alderson P, Bunn F, Lefebvre C, Li WP, Li L, Roberts I, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004:CD001208
- Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. The Albumin Reviewers. Cochrane Database Syst Rev 2000:CD001208.
- Wilkes MM, Navickis RJ. Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med 2001:135:149-64 https://doi.org/10.7326/0003-4819-135-3-200108070-00007
- Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998:317:235-40 https://doi.org/10.1136/bmj.317.7153.235
- Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 1996:9:1736-42 https://doi.org/10.1183/09031936.96.09081736
- Leeper KV Jr, Torres A. Community-acquired pneumonia in the intensive care unit. Clin Chest Med 1995:16:155-71
- Ortqvist A. Initial investigation and treatment of the patient with severe community-acquired pneumonia. Semin Respir Infect 1994:9:166-79
- Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999:159:970-80 https://doi.org/10.1001/archinte.159.9.970